State of Wyoming Has $257,000 Stake in Henry Schein, Inc. (NASDAQ:HSIC)

State of Wyoming lowered its position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 51.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,715 shares of the company's stock after selling 3,873 shares during the quarter. State of Wyoming's holdings in Henry Schein were worth $257,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of the company. Invesco Ltd. raised its holdings in Henry Schein by 0.4% in the fourth quarter. Invesco Ltd. now owns 4,963,409 shares of the company's stock valued at $343,468,000 after acquiring an additional 17,552 shares in the last quarter. FMR LLC raised its holdings in Henry Schein by 6.6% in the fourth quarter. FMR LLC now owns 3,498,033 shares of the company's stock valued at $242,064,000 after acquiring an additional 217,143 shares in the last quarter. Geode Capital Management LLC raised its holdings in Henry Schein by 0.5% in the fourth quarter. Geode Capital Management LLC now owns 3,169,033 shares of the company's stock valued at $218,762,000 after acquiring an additional 14,876 shares in the last quarter. Palestra Capital Management LLC acquired a new stake in Henry Schein in the fourth quarter valued at approximately $182,988,000. Finally, Fiduciary Management Inc. WI raised its holdings in Henry Schein by 7.2% in the fourth quarter. Fiduciary Management Inc. WI now owns 2,488,335 shares of the company's stock valued at $172,193,000 after acquiring an additional 167,990 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company's stock.

Insider Activity

In related news, Director Philip A. Laskawy sold 2,604 shares of the business's stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the transaction, the director now owns 24,805 shares of the company's stock, valued at $1,762,147.20. The trade was a 9.50% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Bradford C. Connett sold 4,036 shares of the business's stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the transaction, the chief executive officer now directly owns 62,688 shares of the company's stock, valued at approximately $4,460,251.20. This trade represents a 6.05% decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on the stock. UBS Group lowered their target price on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 26th. Wells Fargo & Company decreased their target price on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 6th. Barrington Research cut their price target on Henry Schein from $90.00 to $86.00 and set an "outperform" rating for the company in a research note on Tuesday, May 6th. Wall Street Zen downgraded shares of Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday, April 17th. Finally, Piper Sandler cut their target price on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a research note on Wednesday, April 30th. Six analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $79.30.

Henry Schein Stock Performance

Shares of Henry Schein stock traded down $0.19 on Thursday, reaching $73.22. The stock had a trading volume of 203,709 shares, compared to its average volume of 1,658,562. Henry Schein, Inc. has a fifty-two week low of $60.56 and a fifty-two week high of $82.49. The business's 50-day moving average price is $67.62 and its two-hundred day moving average price is $71.59. The stock has a market cap of $8.91 billion, a P/E ratio of 30.12, a price-to-earnings-growth ratio of 2.13 and a beta of 0.87. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings results on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, topping analysts' consensus estimates of $1.11 by $0.04. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. During the same quarter in the previous year, the company earned $1.10 earnings per share. The business's revenue was down .1% compared to the same quarter last year. On average, sell-side analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.